DarkLight mode
News – 19.12.24
Buzzacott advises Rose Street Partners on its investment in Kenwood Damp Proofing PLC
Discover how Buzzacott supported Rose Street Partners on its investment in Kenwood Damp Proofing PLC … Read more
Insight – 18.12.24
Start-up guide: Everything you need to know about Tronc schemes to set your new hospitality business up for success
One challenge for new hospitality businesses is the management of tips and service charges. … Read more
Upcoming event – 16.01.25
VAT on Private School fees training
This in-depth, interactive training seminar is designed to provide school administrators, bursars, finance officers, accountants, and trustees with tailored support and expert insights on the practical implementation of VAT. … Read more
Find us quickly
130 Wood Street, London, EC2V 6DL
enquiries@buzzacott.co.uk T +44 (0)20 7556 1200
Investor: Legacy Health Capital LLC
Seller: Evella Holdings Limited/ Creative Medical Research Limited
Type of deal: Acquisition
Sector: Health and business services – Medical Market research and participant recruitment for medical product fieldwork
Date: March 2023
We're delighted to have played a key role in advising Legacy Health Capital on its acquisition of Evella Holdings Limited which includes the businesses of Creative Medical Research (CMR) and MediVoice Recruit (MVR). These two dynamic companies provide comprehensive healthcare product development and commercial market research and analysis, as well as recruitment for medical product fieldwork research across the US, the UK, and globally.
Under the guidance of the Managing Partner of Legacy Health Capital and CEO of Velox, Suman Datta, the acquisition of Evella Group represents the first acquisition of Velox’s journey. Velox's goal is to build out key services required across the development and commercialisation path of a medical device, diagnostic, and digital health product into a single-source solution. With an experienced team and innovative approach, Velox aims to become the go-to platform for services for the global medical technology industry. Velox is committed to creating a lasting impact in the industry and delivering superior value to its clients.
We had a fantastic experience working with Suman and George Ashford, the Managing Director of the Evella Group, during the due diligence and legal process. Our team worked collaboratively with both buyer and seller to ensure a positive result was achieved, clearly explaining the steps, and taking them through the financial implications of the deal.
We are thrilled to have played a role in this exciting acquisition and look forward to witnessing the continued growth and success of the Evella Group under the guidance of both Suman and George.
To see further transactions in the real estate sector, please see our transactions page.
"It was an absolute pleasure working with Buzzacott throughout the entire acquisition process. Their expert guidance and unwavering support proved to be invaluable at every stage, from the initial planning and due diligence to the complex financial and tax technical aspects of the deal. I would confidently recommend them to any acquirer looking for a dedicated team of professionals who consistently go above and beyond.
I would like to give special recognition to James, whose exceptional skill and expertise were instrumental in bringing both sides of the transaction together. His comprehensive knowledge of the M&A process, coupled with his excellent negotiation skills, played a crucial role in ensuring a smooth and successful acquisition. Without James' guidance and support, the deal would not have been possible. Thank you, James, for your exceptional contribution to our success."
Suman Datta
If you would like to receive notifications of our future deals, or insights from our team on raising finance or selling a business, complete the form below to sign up to our mailing list. You can also leave us a question regarding our services in the text box, and one of our team members will be in touch.
.jpg)
